VYRIKON
Entertainment Systems
A Public Benefit Corporation
The statistics below describe the wider world—not measured results from VYRIKON. They establish why human-centered entertainment, safety, inclusion and belonging deserve rigorous research.
U.S. YOUTH PHYSICAL PARTICIPATION
25.0%In the CDC’s 2025 U.S. Youth Risk Behavior Survey, 25.0% of high-school students reported at least 60 minutes of physical activity on all seven preceding days (95% CI: 23.4–26.7%). This is a measure of physical activity, not VYRIKON participation or physical-entertainment market size.
YOUTH PHYSICAL ACTIVITY
80%WHO reports that 80% of adolescents globally do not meet recommended levels of physical activity. The WHO fact sheet is dated 26 June 2024; this estimate is general background rather than an outcome for VYRIKON.
YOUTH WELL-BEING
33%CDC's 2025 Youth Risk Behavior Survey indicates about one in three U.S. high-school students reported persistent feelings of sadness or hopelessness. Entertainment alone is not a proven treatment.
BELONGING & INCLUSION
22%OECD PISA 2022 country findings for the United States. This is a measure of school belonging, not a measure of event attendance or VYRIKON participation.
IN-PERSON ACTIVITY SAFETY
7 in 10CDC reports that approximately seven in ten emergency-department visits for sports- and recreation-related traumatic brain injuries and concussions involve children aged 17 or younger. This is not an injury rate per participant-hour, nor evidence that VYRIKON is safer. Different activities cannot be directly compared without matched exposures.
SAFETY & FAIRNESS
Safety should be assessed using exposure-adjusted injury and near-miss rates, along with independent review of hazards. Fairness should be assessed through documented officiating accuracy, error rates, consistency across groups, appeal handling, and independent audit. No comparable VYRIKON outcome figures are available yet.
Evidence policy: External prevalence and industry estimates identify relevant needs; prototype and event studies must establish VYRIKON's own effects. Dates, methods, population and limitations should accompany published figures.